A recent study examining the mechanism by which GM-CSF treatment prevents diabetes has further suggested that the expression of OX40L and the Notch3 ligand Jagged1 on DC was necessary for Treg expansion in vitro, although this study did not determine whether these polyclonal expanded Treg were effective in preventing diabetes (141). This evidence concerns the gene CSF2 and diabetes mellitus.